NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 6GFO designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6GFO_NAD_B_1001 | 97% | 26% | 0.052 | 0.976 | 1.19 | 1.68 | 6 | 13 | 0 | 0 | 100% | 1 |
| 6GFO_NAD_A_1001 | 97% | 25% | 0.053 | 0.974 | 1.4 | 1.56 | 8 | 11 | 0 | 0 | 100% | 1 |
| 6GFO_NAD_C_1001 | 96% | 25% | 0.055 | 0.973 | 1.31 | 1.64 | 6 | 11 | 0 | 0 | 100% | 1 |
| 6GFO_NAD_D_1001 | 93% | 26% | 0.066 | 0.966 | 1.28 | 1.62 | 5 | 11 | 0 | 0 | 100% | 1 |
| 4BOY_NAD_A_1001 | 100% | 18% | 0.034 | 0.992 | 2 | 1.49 | 6 | 14 | 0 | 0 | 100% | 1 |
| 6GFQ_NAD_A_1001 | 100% | 30% | 0.036 | 0.991 | 1.15 | 1.53 | 6 | 12 | 0 | 0 | 100% | 1 |
| 6GG7_NAD_A_1001 | 99% | 31% | 0.045 | 0.988 | 1.16 | 1.5 | 6 | 10 | 0 | 0 | 100% | 1 |
| 6GFR_NAD_A_1001 | 98% | 26% | 0.046 | 0.982 | 1.32 | 1.57 | 8 | 10 | 0 | 0 | 100% | 1 |
| 6GFP_NAD_B_1002 | 97% | 29% | 0.053 | 0.976 | 1.19 | 1.56 | 4 | 9 | 1 | 0 | 100% | 0.34 |
| 1DBV_NAD_O_336 | 100% | 18% | 0.012 | 0.999 | 1.39 | 1.98 | 5 | 12 | 0 | 0 | 100% | 1 |
| 1HZJ_NAD_A_400 | 100% | 22% | 0.009 | 0.999 | 1.43 | 1.7 | 8 | 8 | 1 | 0 | 100% | 1 |
| 1OWB_NAD_A_3000 | 100% | 7% | 0.015 | 0.998 | 2.36 | 2.37 | 10 | 13 | 1 | 0 | 100% | 1 |
| 2NAD_NAD_B_394 | 100% | 7% | 0.016 | 0.997 | 2.25 | 2.54 | 14 | 23 | 3 | 0 | 100% | 1 |
| 2QG4_NAD_F_500 | 100% | 19% | 0.017 | 0.998 | 1.81 | 1.58 | 4 | 9 | 0 | 0 | 100% | 1 |
